Over the years, October has become a marketing opportunity for companies that splash pink on their products, suggesting to consumers that they’re helping the breast cancer cause by buying these products. Unfortunately, most of the time very little of the money paid for these products actually goes to breast cancer-related charities. And some of the companies that make these products also produce toxic chemicals that may contribute to an increased risk of breast cancer, Breast Cancer Action explains in their Think Before You Pink project.
What to do instead? There are lots of great alternatives. There are many nonprofit organizations that provide valuable services for those affected by breast cancer or fund critical research. Donating directly to these organizations is a much better alternative to buying pink products. Continue reading
One of the stories that has stood out over the last few years in breast cancer treatment was the FDA’s approval in 2015 of the drug palbociclib (Ibrance) for treatment of hormone receptor-positive metastatic breast cancer (MBC). 
I’m delighted to participate in the 
What are the best ideas for how we could prevent breast cancer in whole populations? This was the big question behind a recent competition sponsored by the California Breast Cancer Research Program. I attended the final round of the competition via livestream and was impressed by the variety and creativity of the proposals presented. 
Learning about progress against cancer has been a main theme here on After Twenty Years since I started this blog about five years ago. One of my first posts in 2013 was a look back at 
Earlier this month, the long-awaited results of the TAILORx clinical trial were announced.
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.
We hear a lot these days about research into promising new immunotherapies and targeted cancer treatments. But when prices for new cancer therapies often exceed $100,000 a year, how many people could realistically be helped by new treatments like these? And 
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this fall.